BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22117639)

  • 21. Recent insights in primary sclerosing cholangitis.
    Ponsioen CY
    J Dig Dis; 2012 Jul; 13(7):337-41. PubMed ID: 22713082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging treatments for primary sclerosing cholangitis.
    Rodriguez EA; Carey EJ; Lindor KD
    Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):451-459. PubMed ID: 28276816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines for therapy of autoimmune liver disease.
    Ishibashi H; Komori A; Shimoda S; Gershwin ME
    Semin Liver Dis; 2007 May; 27(2):214-26. PubMed ID: 17520519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary sclerosing cholangitis: updates in diagnosis and therapy.
    Portincasa P; Vacca M; Moschetta A; Petruzzelli M; Palasciano G; van Erpecum KJ; van Berge-Henegouwen GP
    World J Gastroenterol; 2005 Jan; 11(1):7-16. PubMed ID: 15609388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current treatments of primary sclerosing cholangitis.
    Vacca M; Krawczyk M; Petruzzelli M; Sasso RC; van Erpecum KJ; Palasciano G; van Berge-Henegouwen GP; Moschetta A; Portincasa P
    Curr Med Chem; 2007; 14(19):2081-94. PubMed ID: 17691949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of cholestatic disease in 2017.
    de Vries E; Beuers U
    Liver Int; 2017 Jan; 37 Suppl 1():123-129. PubMed ID: 28052628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of cholestatic liver diseases].
    Karvonen AL
    Duodecim; 2003; 119(6):533-9. PubMed ID: 12708340
    [No Abstract]   [Full Text] [Related]  

  • 28. New therapeutic option with N-acetylcysteine for primary sclerosing cholangitis: two case reports.
    Ozdil B; Cosar A; Akkiz H; Sandikci M; Kece C
    Am J Ther; 2011 May; 18(3):e71-4. PubMed ID: 20019586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic.
    Davies YK; Cox KM; Abdullah BA; Safta A; Terry AB; Cox KL
    J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):61-7. PubMed ID: 18607270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical and endoscopic treatment in primary sclerosing cholangitis.
    Meier PN; Manns MP
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):657-66. PubMed ID: 11492974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overlap syndromes.
    Beuers U; Rust C
    Semin Liver Dis; 2005 Aug; 25(3):311-20. PubMed ID: 16143946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cholestasis: therapeutic options].
    Beuers U; Oswald M
    Ther Umsch; 1998 Feb; 55(2):97-103. PubMed ID: 9545851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cholestatic liver diseases].
    Thimme R; Opitz OG; Blum HE; Kreisel W
    Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cholestatic liver diseases: diagnosis and therapy of primary sclerosing cholangitis].
    Opitz OG; Thimme R; Kreisel W
    Dtsch Med Wochenschr; 2002 Sep; 127(36):1827-30. PubMed ID: 12215927
    [No Abstract]   [Full Text] [Related]  

  • 36. Post-liver transplant cholestatic disorder with biliary strictures: de novo versus recurrent primary sclerosing cholangitis.
    McPartland KJ; Lewis WD; Gordon FD; Pomfret EA; Pomposelli JJ; Jenkins R; Khettry U
    Pathol Int; 2009 May; 59(5):312-6. PubMed ID: 19432673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary sclerosing cholangitis: diagnosis and management.
    Charatcharoenwitthaya P; Lindor KD
    Curr Gastroenterol Rep; 2006 Feb; 8(1):75-82. PubMed ID: 16510038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
    Smith T; Befeler AS
    Curr Gastroenterol Rep; 2007 Mar; 9(1):54-9. PubMed ID: 17335678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary sclerosing cholangitis.
    Rodriguez HJ; Bass NM
    Semin Gastrointest Dis; 2003 Oct; 14(4):189-98. PubMed ID: 14719769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACG Clinical Guideline: Primary Sclerosing Cholangitis.
    Lindor KD; Kowdley KV; Harrison ME;
    Am J Gastroenterol; 2015 May; 110(5):646-59; quiz 660. PubMed ID: 25869391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.